Lightnews — Scholar-powered news

Damon Runyon Cancer Research Foundation @damonrunyon.org · 19d

Earlier this month, we proudly welcomed the newest cohort of Damon Runyon Fellows! These 16 brilliant postdocs will receive four years of independent funding to advance their investigation of causes, treatments, and prevention strategies for all types of cancer. Read more: https://bit.ly/4nc25Hq

1 3

Damon Runyon Cancer Research Foundation @damonrunyon.org · 19d

The recipient of the 2025 Damon Runyon-Jake Wetchler Award for Pediatric Innovation, recognizing work with great potential to impact pediatric cancers, is Pu Zheng, PhD, a Damon Runyon-Fayez Sarofim Fellow working on new technologies to visualize cancer cell behavior within its native environment.

Photo of Pu Zheng standing in front of some laboratory shelving.

Reposted by Damon Runyon Cancer Research Foundation

Jian Zhou @zhou-jian.bsky.social · Jul 23

Wanted to give a proper shout-out to @txrwang.bsky.social for earning a @damonrunyon.org QBio Fellowship! He is a perfect example of the next gen of scientists who think deeply and creatively across disciplines of biology and ML/AI. I learned a lot from him. www.damonrunyon.org/news/entries... 1/2

Damon Runyon Cancer Research Foundation awards Quantitative Biology Fellowships to five cutting-edge scientists

www.damonrunyon.org

1 1 3

Reposted by Damon Runyon Cancer Research Foundation

Luke Timmerman @luketimmerman.bsky.social · Jul 23

Creative Ways to Back Young Scientists. Listen to Yung Lie and Andy Rachleff of Damon Runyon Cancer Research Foundation on The Long Run podcast. timmermanreport.com/2025/07/crea...

Creative Ways to Back Young Scientists: Andy Rachleff and Yung Lie on The Long Run - TimmermanReport.com

Yung Lie and Andy Rachleff are today’s guests on The Long Run. Yung is the president and CEO of the Damon Runyon Cancer Research Foundation, based in New York. Andy is the board chair. Andy was one of...

timmermanreport.com

1 2

Damon Runyon Cancer Research Foundation @damonrunyon.org · Jul 23

Damon Runyon mentor-mentee duo Piro Lito, MD, PhD, and Antonio Cuevas-Navarro, PhD, have developed a new approach to treating RAS-driven cancers, such as colorectal and pancreatic. Rather than inhibiting the cancerous protein, their drug restores its natural function. Read more:

New Discoveries and Honors in Cancer Research | Damon Runyon

www.damonrunyon.org

Reposted by Damon Runyon Cancer Research Foundation

OHSU Knight Cancer Institute @ohsuknight.bsky.social · Jul 21

The Clinical Investigator Award program was designed to increase the number of physician-scientists capable of translating discoveries in the lab into new treatments for cancer patients.

@tanaya-shree.bsky.social was recognized as one of five new @damonrunyon.org Clinical Investigators in 2025.

A graphic featuring a portrait of Dr. Tanaya Shree smiling over a blue-green gradient with text underneath reading, "This generous funding will allow us to study immune responses as they occur in patients receiving bispecific antibodies and help translate the ingredients for successful treatment to more patients. Tanaya Shree M.D., PH.D., OHSU Knight Cancer Institute"

1 1 2

Reposted by Damon Runyon Cancer Research Foundation

OHSU Knight Cancer Institute @ohsuknight.bsky.social · Jul 21

Congratulations to Dr. Tanaya Shree on receiving the 2025 @damonrunyon.org Clinical Investigator Award!

The recipients of this award are outstanding, early-career physician-scientists conducting patient-oriented cancer research under the mentorship of the nation's leading scientists and clinicians.

A portrait of Dr. Tanaya Shree smiling placed over the top of a background image of the Knight Cancer Research Building in a top-down light-to-dar blue gradient. Text underneath reads, "Tanaya Shree, M.D., PH.D., 2025 Clinical Investigator Award, Damon Runyon Cancer Research Foundation"

1 1 1

Reposted by Damon Runyon Cancer Research Foundation

Tanaya Shree @tanaya-shree.bsky.social · Jul 16

Honored to be selected as a Damon Runyon Clinical Investigator among this group of incredible scientists and appreciative of the support to conduct patient-centered mechanistic research. @ohsunews.bsky.social @ohsuknight.bsky.social #CancerImmunotherapy #LymphomaResearch

Damon Runyon Cancer Research Foundation @damonrunyon.org · Jul 15

Congratulations to the newest Damon Runyon Clinical Investigators! The five recipients of this prestigious award are exceptional early-career physician-scientists conducting patient-centered cancer research.

2 3

Damon Runyon Cancer Research Foundation @damonrunyon.org · Jul 15

Learn more about these projects and our new Clinical Investigators:

Damon Runyon Cancer Research Foundation awards $4.2 million to clinical cancer researchers

www.damonrunyon.org

Damon Runyon Cancer Research Foundation @damonrunyon.org · Jul 15

@tanaya-shree.bsky.social‬ is researching the most effective design for a new type of immunotherapy, known as T-cell engaging bispecific antibodies, which bring T cells close to tumor cells and induce them to kill the tumor cell.

1

Damon Runyon Cancer Research Foundation @damonrunyon.org · Jul 15

Srivatsan Raghavan, MD, PhD, aims to uncover how pancreatic cancer cells become resistant to KRAS inhibitors (which target the KRAS gene) and develop combination therapies to overcome this resistance.

1

Damon Runyon Cancer Research Foundation @damonrunyon.org · Jul 15

Peter G. Miller, MD, PhD, studies how mutations in blood cells give rise to pre-malignant blood conditions such as clonal hematopoiesis, which can develop into leukemia. He hopes to develop strategies to predict and prevent lethal blood cancers.

1

Damon Runyon Cancer Research Foundation @damonrunyon.org · Jul 15

@bkeenanmdphd.bsky.social is investigating how liver disease suppresses immune function and interferes with liver cancer treatment. She hopes to find combination therapies that can enhance the effectiveness of immunotherapy for these patients.

1 1

Damon Runyon Cancer Research Foundation @damonrunyon.org · Jul 15

Jonathan Chou, MD, PhD, seeks to identify targetable proteins on the surface of bladder cancer cells, with the goal of engineering new cellular therapies for bladder cancer patients.

1

Damon Runyon Cancer Research Foundation @damonrunyon.org · Jul 15

Congratulations to the newest Damon Runyon Clinical Investigators! The five recipients of this prestigious award are exceptional early-career physician-scientists conducting patient-centered cancer research.

1 2 4

Reposted by Damon Runyon Cancer Research Foundation

michaelpacold.bsky.social @michaelpacold.bsky.social · Jul 9

Out now:

rdcu.be/evxCv

We've used CoQ10 headgroup intermediates to treat mouse models of a mitochondrial disease and improve the neurological symptoms of a patient with this disease.

Grateful for funding from @damonrunyon.org , Pershing Square Foundation, @americancancersoc.bsky.social, NIH!

Coenzyme Q headgroup intermediates can ameliorate a mitochondrial encephalopathy - Nature

Decreased brain coenzyme Q10 levels cause encephalopathy and are associated with neurodegeneration; supplementation with 4-HMA or 4-HB restores coenzyme Q10 synthesis in mice and humans with HPDL vari...

www.nature.com

5 9

Reposted by Damon Runyon Cancer Research Foundation

Luke Timmerman @luketimmerman.bsky.social · Jun 10

Join me at 3 pm Mon. June 16 at the BIO International Convention's Storytelling Stage to hear about the past, present, and future of Timmerman Traverse for @lifesciencecares.bsky.social @damonrunyon.org convention.bio.org/program/bio-...

BIO International Convention | Storytelling Stage

Experience powerful stories from researchers, patients, and innovators at the BIO 2025 Storytelling Stage, June 16–19 in Boston.

convention.bio.org

1 1

Reposted by Damon Runyon Cancer Research Foundation

MSKEducation @mskeducation.bsky.social · Jun 5

🎉 Congratulations to #MSKPostdoc Paul Klauser (@paulklauser.bsky.social), mentored by @lewislabmskcc.bsky.social & @caleblareau.bsky.social, on being awarded the prestigious Damon Runyon Quantitative Biology Fellowship! 👏

Damon Runyon Cancer Research Foundation @damonrunyon.org · Jun 4

Congratulations to the newest Damon Runyon Quantitative Biology Fellows, five exceptional early-career scientists who are using state-of-the-art computational tools to bring cancer biology into high resolution!

2 5

Reposted by Damon Runyon Cancer Research Foundation

Irving Institute for Cancer Dynamics @cancerdynamics.bsky.social · Jun 5

Congrats to IICD postdoc Aaron Zweig (@elhamazizi.bsky.social and @davidaknowles.bsky.social groups), awarded the prestigious Damon Runyon Quantitative Biology Fellowship @damonrunyon.org—one of only five granted this year! 🔗 bit.ly/3TeK7GQ #CancerResearch #QuantBio

2 4

Damon Runyon Cancer Research Foundation @damonrunyon.org · Jun 4

More about the new Quantitative Biology Fellows:

Damon Runyon Cancer Research Foundation awards Quantitative Biology Fellowships to five cutting-edge scientists

www.damonrunyon.org

Damon Runyon Cancer Research Foundation @damonrunyon.org · Jun 4

Aaron Zweig, PhD, is modeling how RNA expression evolves in a cell over time using advanced geometry, deep learning models, and CRISPR gene-editing technology. He aims to be able to predict evolution in regions susceptible to cancerous mutation.

1

Damon Runyon Cancer Research Foundation @damonrunyon.org · Jun 4

Ruoyu Wang, PhD, will combine generative AI models with single-molecule genomics to uncover how mutations in non-coding regions of the human genome contribute to various hallmarks of cancer.

1

Damon Runyon Cancer Research Foundation @damonrunyon.org · Jun 4

Sohyeon Park, PhD, will combine experimental and computational approaches to elucidate how immune cells called macrophages form “memories,” which cause them to either fight tumors or protect them, depending on prior experience.

1

Damon Runyon Cancer Research Foundation @damonrunyon.org · Jun 4

@paulklauser.bsky.social is using advanced protein modeling to develop radiopharmaceuticals, or drugs that contain radioactive forms of chemical elements, to improve diagnostic imaging and targeted radiation therapy.

1 1

Damon Runyon Cancer Research Foundation @damonrunyon.org · Jun 4

Simone Bruno, PhD, will investigate how changes in DNA packaging affect breast cancer progression and treatment response, with the goal of finding ways to mitigate therapy resistance and reduce cancer recurrence.

1